Testing effectiveness (Phase 2)Looking for participantsNCT06440993
What this trial is testing
Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma
Who this might be right for
Extrahepatic CholangiocarcinomaUnresectable Perihilar or Ductal CCA
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 42